Beta-lactamase-producing bacteria and their role in infection

Reviews and Research in Medical Microbiology

Volumn 16, Issue 3, 2005, Pages 91-99

  Brook, Itzhak ^a,b  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

Anaerobic bacteria; Beta lactamase; Haemophilus influenzae; Moraxella catarrhalis; Penicillin; Staphylococcus aureus

Indexed keywords

AMINOGLYCOSIDE; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CARBAPENEM; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN; CLAVULANIC ACID; CLINDAMYCIN; DICLOXACILLIN; ERYTHROMYCIN; LINCOMYCIN; OXACILLIN; PENICILLIN G; PENICILLIN V; PIPERACILLIN PLUS TAZOBACTAM; RIFAMPICIN; SULBACTAM; SULFAFURAZOLE; SULTAMICILLIN; TAZOBACTAM; TETRACYCLINE; TICARCILLIN; TIMENTIN;

ABDOMINAL INFECTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL INFECTION; BACTERIUM ISOLATION; BACTEROIDES; CHEMOPROPHYLAXIS; CLINICAL TRIAL; DRUG EFFICACY; ENZYME INACTIVATION; FUSOBACTERIUM NUCLEATUM; FUSOBACTERIUM VARIUM; GRAM NEGATIVE BACTERIUM; GYNECOLOGIC INFECTION; HAEMOPHILUS INFLUENZAE; HUMAN; LEGIONELLA PNEUMOPHILA; MAXILLA SINUSITIS; MIXED INFECTION; MORAXELLA CATARRHALIS; MOUTH INFECTION; NEISSERIA GONORRHOEAE; NONHUMAN; OTITIS MEDIA; PATHOGENICITY; PELVIC INFLAMMATORY DISEASE; PHARYNGITIS; PORPHYROMONAS; PREVOTELLA; PRIORITY JOURNAL; RECURRENT INFECTION; REVIEW; SEXUALLY TRANSMITTED DISEASE; SKIN INFECTION; SOFT TISSUE INFECTION; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS GROUP A; SURGICAL INFECTION; TONSILLECTOMY; TONSILLITIS; TREATMENT FAILURE; UPPER RESPIRATORY TRACT INFECTION;

EID: 23044509476     PISSN: 0954139X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.revmedmi.0000174967.28926.24     Document Type: Review

References (77)

1. Doern GV. Resistance among problem respiratory pathogens in pediatrics. Pediatr Infect Dis J 1995; 14:420-423.
2. Richter SS, Brueggemann AB, Huynh HK, Rhomberg PR, Wingert EM, Flamm R, et al. A 1997-1998 national surveillance study: Moraxella catarrhalis and Haemophilus influenzae antimicrobial resistance in 34 US institutions. Int J Antimicrob Agents 1999; 13:99-107.
3. Brook I, Calhoun L, Yocum P. Beta-lactamase-producing isolates of Bacteroides species from children. Antimicrob Agents Chemother 1980; 18:264-266.
4. Brook I. The role of beta-lactamase-producing bacteria in the persistence of streptococcal tonsillar infection. Rev Inf Dis 1984; 6:601-607.
5. Bush K. Beta-lactamases of increasing clinical importance. Curr Pharm Des 1999; 5:839-845.
6. Ambler RP. The structure of beta-lactamases. Philos Trans R Soc Lond (Biol) 1980; 289:321-331.
7. Richmond MH, Sykes RB. The beta-lactamases of Gram-negative bacteria and their possible physiological role. Adv Microb Physiol 1973; 9:31-88.
8. Bush K. The impact of beta-lactamases on the development of novel antimicrobial agents. Curr Opin Investig Drugs 2002; 3:1284-1290.
9. Sturenburg E, Mack D. Extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory, therapy, and infection control. J Infect 2003; 47:273-295.
10. Larson LL, Ramphal R. Extended-spectrum beta-lactamases. Semin Respir Infect 2002; 17:189-194.
11. Mastrantonio P, Cardines R, Spigaglia P. Oligonucleotide probes for detection of cephalosporinases among Bacteroides strains. Antimicrob Agents Chemother 1996; 40:1014-1016.
12. Tuner K, Lennart L, Nord CE. Purification and properties of a novel beta-lactamase from Fusobacterium nucleatum. Antimicrob Agents Chemother 1985; 27:943-947.
13. Nikaido H, Vaava M. Molecular basis of bacterial outer-membrane permeability. Microbiol Rev 1985; 49:1-32.
14. Hakenbeck R, Grebe T, Zahner D, Stock JB. Beta-lactam resistance in Streptococcus pneumoniae: penicillin-binding proteins and non-penicillin-binding proteins. Mol Microbiol 1999; 33:673-678.
15. Massova I, Mobashery S. Structural and mechanistic aspects of evolution of beta-lactamases and penicillin-binding proteins. Curr Pharm Des 1999; 5:929-937.
16. Maiti SN, Phillips OA, Micetich RG, Livermore DM. Beta-lactamase inhibitors: agents to overcome bacterial resistance. Curr Med Chem 1998; 5:441-456.
17. Williams JD. Beta-lactamases and beta-lactamase inhibitors. Int J Antimicrob Agents 1999; 12 (Suppl 1):S3-S7.
18. Brook I. Recovery of beta-lactamase producing bacteria in pediatric infections. Can J Microbiol 1987; 33:888-895.
19. Brook I, Frazier EH, Thomas RL. Aerobic and anaerobic microbiologic factors and recovery of beta-lactamase producing bacteria from obstetric and gynecologic infection. Surg Gynecol Obstet 1991; 172:138-144.
20. Eschenbach DA. A review of the role of beta-lactamase producing bacteria in obstetric-gynecologic infection. Am J Obstet Gynecolog 1987; 156:495-503.
21. Ross J. Pelvic inflammatory disease. BMJ 2001; 322:658-659.
22. Tomeh MO, Starr SE, McGowan JE Jr. Ampicillin-resistant Haemophilus influenzas type b infection. JAMA 1974; 229:295.
23. Hoban DJ, Doern GV, Fluit AC, Roussel-Delvallez M, Jones RN. Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis 2001; 15;32 Suppl 2:S81-S93.
24. Campos J, Roman F, Perez-Vazquez M, Oteo J, Aracil B, Cercenado E, Spanish Study Group for Haemophilus influenzae Type E. Infections due to Haemophilus influenzae serotype E: microbiological, clinical, and epidemiological features. Clin Infect Dis 2003; 37:841-855.
25. Hoban D, Felmingham D. The PROTEKT surveillance study: antimicrobial susceptibility of Haemophilus influenzae and Moraxella catarrhalis from community-acquired respiratory tract infections. J Antimicrob Chemother 2002; 50 (Suppl S1):49-59.
26. Enright MC, McKenzie H. Moraxella (Branhamella) catarrhalis-clinical and molecular aspects of a rediscovered pathogen. J Med Microbiol 1997; 46:360-371.
27. Jacobs MR. Worldwide trends in antimicrobial resistance among common respiratory tract pathogens in children. Pediatr Infect Dis 2003; 22 (8 Suppl):S109-S119.
28. Seigel WM, Golden NH, Weinberg S, Sacker IM. Hyperendemic penicillinase-producing Neisseria gonorrhoeae genital infections in an inner city population. J Adolesc Health 1995; 16:41-44.
29. Ison CA. Antimicrobial agents and gonorrhoea: therapeutic choice, resistance and susceptibility testing. Genitourin Med 1996; 72:253-257.
30. Roig J, Sabria M, Pedro-Botet ML. Legionella spp.: community acquired and nosocomial infections. Curr Opin Infect Dis 2003; 16:145-151.
31. Campins M, Ferrer A, Callis L, Pelaz C, Cortes PJ, Pinart N, Vaque J. Nosocomial Legionnaire's disease in a children's hospital. Pediatr Infect Dis J 2000; 19:228-234.
32. Barker J, Brown MR. Speculations on the influence of infecting phenotype on virulence and antibiotic susceptibility of Legionella pneumophila. J Antimicrob Chemother 1995; 36:7-21.
33. Brook I. Anaerobic bacterial bacteremia: 12-year experience in two military hospitals. J Infect Dis 1989; 160:1071-1075.
34. Brook I. Infections caused by beta-lactamase-producing Fusobacterium spp. in children. Pediatr Infect Dis J 1993; 12:532-533.
35. Goldstein EJ, Summanen PH, Citron DM, Rosove MH, Finegold SM. Fatal sepsis due to a beta-lactamase-producing strain of Fusobacterium nucleatum subspecies polymorphum. Clin Infect Dis 1995; 20:797-800.
36. Brook I, Pazzaglia G, Coolbaugh JC, Walker RI. In vivo protection of group A beta-hemolytic streptococci by beta-lactamase producing Bacteroides species. J Antimicrob Chemother 1983; 12:599-606.
37. Brook I, Pazzaglia G, Coolbaugh JC, Walker RI. In vivo protection of penicillin susceptible Bacteroides melaninogenicus from penicillin by facultative bacteria which produce beta-lactamase. Can J Microbiol 1984; 30:98-104.
38. Simon HM, Sakai W. Staphylococcal anatagosim to penicillin group therapy of hemolytic streptococcal pharyngeal infection: Effect of oxacillin. Pediatrics 1963; 31:463-469.
39. Brook I, Yocum P. In vitro protection of group A beta-hemolytic streptococci from penicillin and cephalothin by Bacteroides fragilis. Chemotherapy 1983; 29:18-23.
40. De Louvois J, Hurley R. Inactivation of penicillin by purulent exudates. BMJ 1977; 2:998-1000.
41. Bryant RE, Rashad AL, Mazza JA, Hammond D. Beta-lactamase activity in human plus. J Infect Dis 1980; 142:594-601.
42. Brook I. Quantitative cultures and beta-lactamase activity in chronic suppurative otitis media. Ann Otol Rhinol Laryngol 1989; 98:293-297.
43. Brook I, Yocum P. Bacteriology and beta-lactamase activity in ear aspirates of acute otitis media that failed amoxicillin therapy. Pediatr Infect Dis J 1995; 14:805-808.
44. Brook I, Yocum P, Frazier EH. Bacteriology and beta-lactamase activity in acute and chronic maxillary sinusitis. Arch Otolaryngol Head Neck Surg 1996; 122:418-422.
45. Heimdahl A, Von Konow L, Nord CE. Isolations of beta-lactamase-producing Bacteroides strains associated with clinical failures with penicillin treatment of human orofacial infections. Arch Oral Biol 1980; 25:288-292.
46. Brook I. Beta-lactamase-producing bacteria recovered after clinical failures with various penicillin therapy. Arch Otolaryngol 1984; 110:228-231.
47. Quentin R, Lansac J. Pelvic inflammatory disease: medical treatment. Eur J Obstet Gynecol Reprod Biol 2000; 92:189-192.
48. Smith TD, Huskins WC, Kim KS, Kaplan EL. Efficacy of beta-lactamase- resistant penicillin and influence of penicillin tolerance in eradicating streptococci from the pharynx after failure of penicillin therapy for group A streptococcal pharyngitis. J Pediatr 1987; 110:777-782.
49. Kaplan EL, Johnson DR. Unexplained reduced microbiological efficacy of intramuscular benzathine penicillin G and of oral penicillin V in eradication of group A streptococci from children with acute pharyngitis. Pediatrics 2001; 108:1180-1186.
50. Knudsin RB, Miller JM. Significance of the Staphylococcus aureus carrier state in the treatment of disease due to group A streptococci. N Engl J Med 1964; 271:1395-1397.
51. Quie PG, Pierce AX, Wannamaker LW. Influence of penicillinase producing staphylococci on the eradication of group A streptococci from the upper respiratory tract by penicillin treatment. Pediatrics 1966; 37:467-476.
52. Kovatch AL, Wald ER, Michaels RH. Beta-lactamase-producing Branhamella catarrhalis causing otitis media in children. J Pediatr 1983; 102:260-263.
53. Brook I, Yocum P, Friedman EM. Aerobic and anaerobic flora recovered from tonsils of children with recurrent tonsillitis. Ann Otol Rhinol Laryngol 1981; 90:261-263.
54. Brook I, Yocum P. Quantitative measurement of beta-lactamase levels in tonsils of children with recurrent tonsillitis. Acta Otolaryngol Scand 1984; 98:456-459.
55. Reilly S, Timmis P, Beeden AG, Willis AT. Possible role of the anaerobe in tonsillitis. J Clin Path 1981; 34:542-547.
56. Chagollan JR, Macias JR, Gil JS. Flora indigena de las amigalas. Investigacion Medical Internacional 1984; 11:36-43.
57. Tuner K, Nord CE. Beta lactamase-producing microorganisms in recurrent tonsillitis. Scand J Infect Dis Suppl 1984; 39:83-85.
58. Tuner K, Nord CE. Emergence of beta-lactamase producing microorganisms in the tonsils during penicillin treatment. Eur J Clin Microb 1986; 5:399-404.
59. Brook I, Gober AE. Emergence of beta-lactamase-producing aerobic and anaerobic bacteria in the oropharynx of children following penicillin chemotherapy. Clin Pediatr (Phila) 1984; 23:338-341.
60. Brook I. Emergence and persistence of β-lactamase-producing bacteria in the oropharynx following penicillin treatment. Arch Otolaryngol Head Neck Surg 1988; 114:667-670.
61. Brook I, Gober AE. Prophylaxis with amoxicillin or sulfisoxazole for otitis media: effect on the recovery of penicillin-resistant bacteria from children. Clin Infect Dis 1996; 22:143-145.
62. Brook I. Role of beta-lactamase-producing bacteria in penicillin failure to eradicate group A streptococci. Pediatr Infect Dis 1985; 4:491-495.
63. Roos K, Grahn E, Holn SE. Evaluation of beta-lactamase activity and microbial interference in treatment failures of acute streptococcal tonsillitis. Scand J Infect Dis 1986; 18:313-318.
64. Brook I, Gober AE. Resistance to antimicrobials used for the therapy of otitis and sinusitis: effect of previous antimicrobial therapy and smoking. Ann Otol Rhinol Laryngol 1999; 108:645-647.
65. Brook I, Hirokawa R. Treatment of patients with recurrent tonsillitis due to group A beta-hemolytic streptococci: A prospective randomized study comparing penicillin, erythromycin and clindamycin. Clin Pediatr 1985; 24:331-336.
66. Orrling A, Stjernquist-Desatnik A, Schalen C. Clindamycin in recurrent group A streptococcal pharyngotonsillitis-an alternative to tonsillectomy? Acta Otolaryngol 1997; 117:618-622.
67. Tanz RR, Poncher JR, Corydon KE, Kabat K, Yogev R, Shulman ST. Clindamycin treatment of chronic pharyngeal carriage of group A streptococci. J Pediatr 1991; 119:123-128.
68. Chaudhary S, Bilinsky SA, Hennessy JL, Soler SM, Wallace SE, Schacht CM, Bisno AL. Penicillin V and rifampin for the treatment of group A streptococcal pharyngitis: A randomized trial of 10 days penicillin vs. 10 days penicillin with rifampin during the final 4 days of therapy. J Pediatr 1985; 106:481-486.
69. Tanz RR, Shulman ST, Barthel MJ, Willert C, Yogev R. Penicillin plus rifampin eradicate pharyngeal carrier of group A streptococci. J Pediatr 1985; 106:876-880.
70. Brook I. Treatment of patients with acute recurrent tonsillitis due to group A beta-haemolytic streptococci: a prospective randomized study comparing penicillin and amoxycillin/clavulanate potassium. J Antimicrob Chemother 1989; 24:227-233.
71. Brook I, Shah K, Jackson W. Microbiology of healthy and diseased adenoids. Laryngoscope 2000; 110:994-999.
72. Brook I, Shah K. Effect of amoxycillin with or without clavulanate on adenoid bacterial flora. J Antimicrob Chemother 2001; 48:269-273.
73. Brook I, Shah K. Effect of amoxicillin or clindamycin on the adenoids bacterial flora. Otolaryngol Head Neck Surg 2003; 129:5-10.
74. Brook I, Gober AE. Effect of amoxicillin and co-amoxiclav on the aerobic and anaerobic nasopharyngeal flora. J Antimicrob Chemother 2002; 49:689-692.
75. Levison ME, Mangura CT, Lorber B, Abrutyn E, Pesanti EL, Levy RS, MacGregor RR, Schwartz AR. Clindamycin compared with penicillin for the treatment of anaerobic lung abscess. Ann Intern Med 1983; 98:466-471.
76. Gudiol F, Manresa F, Pallares R, Dorca J, Rufi G, Boada J, Ariza X, Casanova A, Viladrich PF. Clindamycin vs penicillin for anaerobic lung infections. High rate of penicillin failures associated with penicillin-resistant Bacteroides melaninogenicus. Arch Intern Med 1990; 150:2525-2529.
77. Brook I. Treatment of aspiration or tracheostomy-associated pneumonia in neurologically impaired children: effect of antimicrobials effective against anaerobic bacteria. Int J Pediatr Otorhinolaryngol 1996; 35:171-177.